Seduction by induction?

Journal of Clinical Oncology

Volumn 27, Issue 1, 2009, Pages 9-10

  Beitler, Jonathan J ^a   Cooper, Jay S ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Maimonides Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; GOLD STANDARD; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; SHORT SURVEY; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

CLINICAL TRIALS, PHASE III AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 58149327465     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.5875     Document Type: Short Survey

References (15)

1. Wikipedia: Inductive reasoning. http://en.wikipedia.org/wiki/lnductive- reasoning
2. Posner MR, Hershock DM, Blajman CR, et al: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705-1715, 2007
3. Vermorken JB, Remenar E, van Herpen C, et al: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695-1704, 2007
4. Kies MS: Induction chemotherapy should be standard of care for advanced head and neck cancer. Presented at the 44th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, May 30-June 3, 2008
5. Bourhis J, Le Maitre A, Baujat B, et al: Individual patients' data meta-analyses in head and neck cancer. Curr Opin Oncol 19:188-194, 2007
6. Wendt TG, Grabenbauer GG, Rodel CM, et al: Simultaneous radiochemo-therapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1324, 1998
7. Denis F, Garaud P, Bardet E, et al: Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage orophar-ynx carcinoma. J Clin Oncol 22:69-76, 2004
8. S. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567-578, 2006
9. Ajani JA, Winter KA, Gunderson LL, et al: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 299:1914-1921, 2008
10. Curran WJ, Scott C, Langer C, et al: Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410. Proc. Am Soc Clin Oncol 19:1891a, 2000
11. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vin-desine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692-2699, 1999
12. Vokes EE, Herndon JE 2nd, Kelley MJ, et al: Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25:1698-1704, 2007
13. Murray N, Coy P, Pater JL, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer: The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 11:336-344, 1993
14. Tsukada H, Yokoyama A, Goto K, et al: Concurrent versus sequential radiotherapy for small cell lung cancer. Semin Oncol 28:23-26, 2001
15. Mauri D, Pavlidis N, loannidis JP: Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis. J Natl Cancer Inst 97:188-194, 2005